Glutaminase-1 Inhibitor IACS-6274 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: GLS1 Inhibitor IACS-6274, IACS 6274, IACS-6274, IACS6274, IPN 60090 +2 more

Pipeline

Phase 1: 1

Top Sponsors

M.D. Anderson Cancer Center1

Indications

Refractory Ovarian High Grade Serous Adenocarcinoma1
Refractory Ovarian Clear Cell Adenocarcinoma1
Refractory Melanoma1
Refractory Endometrial Carcinoma1
Advanced Ovarian Clear Cell Adenocarcinoma1

Houston, Texas1 trial

IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors

M D Anderson Cancer Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.